Entero Healthcare Solutions ENTERO
Pan-India pharma and healthcare-product distributor consolidating fragmented regional wholesalers
Mapped in 1 theme: Pharmaceuticals.
Where Entero Healthcare Solutions sits in the supply chain
Entero Healthcare Solutions appears in 1 supply-chain layer in one theme, Pharmaceuticals.
Pharmaceuticals › Distribution & pharmacy retail
OperatorOther companies in this layer
Revenue and profit
| ₹ Cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 3,922 | 5,096 | 6,591 |
| Net profit | 40 | 107 | 146 |
Latest-year revenue ₹6,591 Cr (FY26, company-wide). Wider screens show FY22 onwards.
Strengths
- Fast growth from acquisitions and new territories - revenue up ~2.6x FY22-FY26
- Turned profitable and scaling margins as acquired distributors integrate
Risks
- Thin distribution margins and high working capital
- Acquisition-integration risk; ROE still single digit
Common questions
What does Entero Healthcare Solutions do?
Pan-India pharma and healthcare-product distributor consolidating fragmented regional wholesalers.
Where does Entero Healthcare Solutions sit in the supply chain?
Entero Healthcare Solutions (NSE: ENTERO) is mapped in 1 supply-chain layer: Distribution & pharmacy retail (Pharmaceuticals).
Who are Entero Healthcare Solutions' peers?
In the Distribution & pharmacy retail layer of Pharmaceuticals: MedPlus Health Services, Apollo Hospitals Enterprise, PharmEasy (API Holdings) (not NSE-listed) and Tata 1mg (not NSE-listed).
What is Entero Healthcare Solutions' market cap and valuation?
As of 30 Oct 2026: market cap ₹6,856 Cr, P/E 53.1x, ROCE 10.5%, ROE 6.9%, dividend yield 0%.